Mayo germ-free eggs company raises €1.1m

  • 📰 IrishTimes
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 98%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Biotech business has developed process of producing germ-free birds and eggs

Dr Martin Murphy, project director; Dr Catherine Caulfield, co-founder and chief executive; and Dr Leonard Moran co-founder and chairman of Ovagen. The company's germ-free eggs are used primarily in the pharmaceutical industry.Mayo-based Ovagen has raised €1.1 million in funding and said it expects to add 65 jobs in the next five years as it further develops its germ-free eggs.

The funding round was led by Halso Business Angel Network through its Irrus Investments and WxNW syndicates. The round, which was oversubscribed, was also backed by the Western Development Commission and an existing shareholder. The latest round brings the total raised by Ovagen to more than €19 million to date.

The biotechnology company has developed a process of producing germ-free chicken eggs and germ-free birds, primarily for use in the pharmaceutical industry Where more than one billion eggs are used globally each year. The eggs are used to support the development of vaccines for both animals and humans, for diseases such as flu, yellow fever, mumps and measles.

The funding will be used to expand staff numbers, carry out evaluation trials on vaccine batches made using the eggs, and officially launch the eggs to pharmaceutical manufacturers.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 3. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인